纵横研报
Ticker Detail

603168.SHG

¥5.18+2.57% 莎普爱思 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Zhejiang Shapuaisi Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. It also offers medical and health care, and scientific research and teaching facilities. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

MARKET 市值 1.86B CNY 52W ¥4.55 – ¥9.09 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -3.2% ROE -18.7% 营业利润率 6.6% 净利润率 -59.6%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制